New Hampshire Pharmacies Could Soon Begin Dispensing

New Post Public Reply Private Reply Replies (0) Message Board
energy_wave
247
New Hampshire Pharmacies Could Soon Begin Dispensing Ivermectin Without Doctor's Prescription
Quote:


by Tyler Durden
Sunday, Jan 23, 2022 - 02:55 PM

A bill working its way through the New Hampshire legislature would allow residents to receive ivermectin from pharmacies with a prescription of a doctor or an Advanced Practice Registered Nurse (APRN) for the off-label treatment of Covid-19.

House Bill 2011 would allow pharmacists to "dispense ivermectin under the delegated prescriptive authority of the physician or APRN (Advanced Practice Registered Nurses), specify a mechanism to document screening performed and the prescription in the patient's medical record, and include a plan for evaluating and treating adverse events," reads the bill. "Any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice."

Ivermectin, a protease inhibitor (just like Pfizer's new Covid pill), has come under attack ever since former President Trump suggested it as a potential treatment for Covid-19. Shortly thereafter, a flurry of anti-ivermectin studies came out - the majority of which analyzed already-hospitalized patients, as opposed to its use as an early intervention.
via ivmmeta.com

Indeed, ivermectin already may have saved hundreds of thousands of lives from India to Brazil.

Co-sponsored by Rep. Leah Cushman (R), the New Hampshire bill would require pharmacists to provide patients with a "standardized information sheet written in plain language" that would note the importance of follow-up care.

"Nothing on the information sheet shall discourage the recipient from using ivermectin for the treatment of COVID-19," reads the bill.

On Tuesday, a state House committee heard arguments for and against the bill.

"Ivermectin is not authorized or approved by the FDA for use in preventing or treating COVID-19," said Steve Ahnen, president and CEO of the New Hampshire Hospital Association.

Arguing for Ivermectin was Dr. Paul Marik with Front Line COVID-19 Critical Care Alliance, who resigned his position as Professor of Medicine with Eastern Virginia Medical School following a reprimand from the Virginia Board of Medicine for proscribing drugs to people who were not his patients.

Marik has over 400 peer-reviewed journal articles and 50 book chapters under his belt.

Some key excerpts from his testimony can be seen below via Granite Grok:

This is not controversial. It has been made controversial by politics and special interests.

I’ve been practicing critical care for 35 years.

I’ve published over 600 peer reviewed papers.

After penicillin, this is the second most important drug ever produced. It has saved hundreds of thousands of lives across this planet in poor underserved countries. So, we’re just going to talk about Ivermectin.

It is on the WHO’s list of essential medicines.

3.7 Billion doses have been dispensed to humans, to human beings… not horses.

This is a remarkable drug. It has broad spectrum anti-parasitic, effective against a whole bunch of parasites, and as we heard, it is very effective against RNA viruses: HIV virus, zika virus, influenza virus, SARS-CoV-2 virus. In addition, what makes this a truly astonishing drug, and there is no other drug like it, it is a potent anti-inflamatory drug.

And if anybody knows about Covid, Covid goes through stages. A viral replicative phase to a profound inflammatory phase. That’s why Ivermectin is unique in that it treats across the spectrum of SARS-CoV-2.

It’s safe and well tolerated.

Ivermectin acts on a number of different pathways to inhibit viral replication. This is not theoretical. This is shown in the lab and this is shown in patients … it kills the virus. So any assumption that it doesn’t is false propaganda.”

You’ll see an 83% improvement in prophylaxis trials. 66% improvement in early trials. 34% improvement in late trials. A 52% reduction in mortality. It reduces mortality by half.

More via Granite Grok:

Dr. Marik left no stone unturned, and addressed the FDA’s propaganda statement, “You are not a horse. You are not a cow. Seriously y’all. Stop it. You should not use Ivermectin to treat or prevent Covid-19 using the drug Ivermectin which can be dangerous and even lethal.”

So that is an outright lie. It’s dishonest and it’s an outrage.

As we’ll see, this is a highly effective drug, and Ivermectin has never killed a single person. It is one of the safest drugs on this planet.

What is really interesting is Ivermectin is safe in 79 countries in the world. Let me say that again… it is approved in 79 countries.

Let’s look at Covid-19 vaccines in one year: 14 thousand deaths and over two million serious adverse events. This does not include the 20,000 deaths in the VAERS database which is probably a tenth of all deaths due to the vaccine. This is their data.

So somehow the SARS-CoV-2 vaccines are safe and effective, yet Ivermectin is a dangerous horse deworming medicine. That is an absolute outright lie. The data speaks for itself. This is not my data. This is from the WHO.

More people have died from Tylenol, which is an over-the-counter medicine, than Ivermectin. As I said, it is one of the safest medications on this planet.


https://www.zerohedge.com/covid-19/new-hampsh...ut-doctors
big-wave_surfing_01.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PepsiCo Joins AAG in 7-Year Multimillion-Dollar Deal

Updated Category News Views 1

The sports world isn’t just about the scores on the field; it’s also about the names and logos plastered everywhere you look. And here comes PepsiCo, striding confidently into the Arizona Athletic Grounds (AAG) arena with the gusto of a heavyweight looking to make some serious gains. Big Brand, Big Moves: What This Means for AAG This isn’t your run-of-the-mill...

Continue Reading
Sceye's Stratospheric Leap: A Revolution in Connectivity

Updated Category News Views 3

Sceye's Game-Changer: Stratospheric Connectivity Breakthrough Every once in a while, a tech leap makes folks sit up straight. Maybe it's the allure of a new gadget or a mind-blowing application that spells out change in big, bold letters. Well, Sceye just lobbed one over the Pacific that's like a stone-cold revolution in the world of connectivity. Imagine a game of chess...

Continue Reading
Axjo Group Expands in France with Eco-Tourets Buy

Updated Category News Views 6

Seizing the French Market: Axjo's Strategic Play Every now and then, you come across a company that's not just talking the talk but walking the green walk. Axjo Group's latest move—scooping up France's Eco-Tourets—puts them squarely in that league. It ain't just about expanding the footprint; it's about owning a piece of the future where sustainability isn't a...

Continue Reading
BOC Group's Challenger Role Eye-Opener in Gartner Quadrant

Updated Category News Views 6

Cracking the Challenger Code: BOC Group's Debut Ever heard of BOC Group? If you haven’t, it’s time to pay attention. This Dublin-based outfit just muscled its way into the Challenger Quadrant of the 2026 Gartner Magic Quadrant for Digital Twin of an Organization Platforms. Not bad for its first trip to the dance. When a company crashes the scene like this, eyebrows...

Continue Reading
Elbphilharmonie Hamburg: 10th Anniversary Marks Milestone

Updated Category News Views 4

Elbphilharmonie's Impact on Hamburg's Cultural Landscape Here we are, staring down the first decade of the Elbphilharmonie, and boy, if that isn't a testament to sticking your neck out for culture, I don't know what is. Opened back on January 11, 2017, this concert hall started as just another controversial project, folks wagging tongues about costs and ambition. But...

Continue Reading
Charter CFO to Speak at Citi TMT Conference 2026

Updated Category News Views 10

Charting Charter's Future Moves at the Citi TMT Conference There's something electric about a company like Charter Communications showing up at a big-deal event like the Citi Global TMT Conference. It's not just another day in the office when Jessica Fischer, the Chief Financial Officer, steps up to the mic on September 10, 2026. Investors better have their ears perked...

Continue Reading
ASUS Harnesses AI Power with ProArt RTX Spark PCs

Updated Category News Views 3

When ASUS throws its hat in the ring, you know it's going for the knockout. At IFA 2026, they're swinging for the fences with their new ProArt lineup—powered by NVIDIA RTX Spark. We're talking serious AI muscle here, up to 1 petaflop worth! What Makes This Lineup a Game Changer? The ProArt series, comprising of the P16 and P14 laptops, alongside the GR1X mini PC, is a...

Continue Reading
PMI Foods Fuels Hunger Action Month with New Partnership

Updated Category News Views 2

Helping Families Put Food on the Table Out there in Utah's schoolyards, Parker Migliorini International (PMI Foods) is taking a tangible step against hunger, whipping out a $15,000 check to back the Utah Food Bank’s Mobile School Pantry initiative. This partnership kicks off in September, aligning with Hunger Action Month, a period dedicated to spotlighting food...

Continue Reading
Jeen's Real-Time AI Cost Management Unveiled

Updated Category News Views 2

Unmasking the Ghosts in AI Expenses Enterprises are thrashing around in the digital ocean of AI, yet many still can't see what's draining their coffers. It's not just the savant data scientists racking up the charges; it's every automated agent chipping away at resources—unnoticed until the bill finally lands. That's where Jeen is stepping in, flipping the script on...

Continue Reading
Fly-E Faces Hurdles: Revenue Halved, Losses Soar

Updated Category News Views 2

Shifting Gears in Rough Terrain Fly-E Group, Inc., known on the NASDAQ as FLYE, is having a hell of a ride these days. The latest quarterly figures? Not exactly inspiring, unless you're into shooting yourself in the foot. With net revenues diving over 48% to just $2.7 million and net losses ballooning to $3.9 million, these numbers aren't painting a pretty picture for...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Tomorrow's Marketers: Daniels College Board Unveils Plans

Updated Category News Views 290

Empowering Tomorrow's Marketers at Daniels College of Business The University of Denver Daniels College of Business is thrilled to inform the community about the formation of its Marketing Advisory Board for the 2024-2025 academic year. The board is spearheaded by influential leaders in the field, aiming to enrich the marketing education landscape. Co-chaired by Jack...

Continue Reading
Treatment.com AI: Transforming Patient Care with AI Insights

Updated Category News Views 116

Transforming Patient Care with AI Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) is a healthcare technology company that is reshaping patient care through AI-driven clinical insights. Recently, they supported a forward-thinking event that brought together 25 of the nation’s leading experts to discuss the effective use of artificial intelligence (AI) in...

Continue Reading
Investors Urged to Understand Their Rights with Midnight Hub NFTs

Updated Category News Views 115

Understanding Your Rights as an Investor In a rapidly evolving digital landscape, the rise of non-fungible tokens (NFTs) has brought exciting opportunities and corresponding challenges. One notable player in this space is Midnight Hub, a platform that has launched various NFTs, including the Digital Nomads NFTs. Due to a recent class action lawsuit, the Rosen Law Firm is...

Continue Reading
Optical Fiber Polarizer Market Set to Reach USD 14.5 Billion by 2030

Updated Category News Views 55

Overview of the Optical Fiber Polarizer Market The optical fiber polarizer market is experiencing notable growth, largely fueled by the increasing demand for high-speed data transmission. As various industries continue to innovate, advancements in telecommunications technology significantly influence this market. The complex components found in optical fiber polarizers...

Continue Reading
Understanding Prescription Fraud: Legal Insights and Consequences

Updated Category News Views 129

Understanding Prescription Fraud and Its Legal Ramifications Prescription drug abuse has become a significant issue in recent times, with many individuals facing severe legal consequences due to prescription fraud. Although this crime is often associated with patients seeking extra medications, it is essential to recognize that healthcare professionals can also be...

Continue Reading